HLA-DQ6 transgenic mice resistance to experimental autoimmune myasthenia gravis is linked to reduced acetylcholine receptor-specific IFN-gamma, IL-2 and IL-10 production
Ma. Poussin et al., HLA-DQ6 transgenic mice resistance to experimental autoimmune myasthenia gravis is linked to reduced acetylcholine receptor-specific IFN-gamma, IL-2 and IL-10 production, J AUTOIMMUN, 17(3), 2001, pp. 175-180
To comprehend the reduced susceptibility of HLA-DQ6 transgenic mice in comp
arison with HLA-DQ8 mice, to experimental autoimmune myasthenia gravis. (EA
MG), we immunized them with acetylcholine receptor (AChR) and examined in v
itro, the proliferative and cytokine responses to AChR. When immunized with
AChR and examined for AChR-specific lymphocyte responses to AChR, EAMG-res
istant DQ6 mice exhibited significantly reduced in vitro lymphoproliferativ
e and cytokine responses to AChR, compared to DQ8 mice. The differences in
susceptibility were not linked to a difference in peptide recognition by AC
hR-specific lymphocytes. AChR T cell epitope mapping showed that both DQ6 a
nd DQ8 responded to the same epitopes, although to varying degrees. Resista
nce of DQ6 transgenic mice to EAMG was linked to a dramatic suppression of
AChR-specific IFN-gamma, IL-2 and IL-10 productions by AChR-primed lymph no
de cells. (C) 2001 Academic Press.